Literature DB >> 2856689

Free intracellular calcium in essential hypertension. Effects of nifedipine and captopril.

T Lenz1, H Haller, M Lüdersdorf, A Kribben, M Thiede, A Distler, T Philipp.   

Abstract

The acute effects of nifedipine (20 mg sublingually) and of captopril (12.5 mg orally) on blood pressure and on platelet intracellular free calcium were investigated in 11 and 12 patients, respectively, with essential hypertension. Platelet calcium was measured by the Quin 2 method. Application of both drugs resulted in a significant fall in blood pressure within 60 min. Platelet calcium, however, was lowered by nifedipine only. There was no correlation between blood pressure reduction and changes in platelet calcium. Platelet intracellular free calcium concentration was 99 +/- 3 nmol in 30 normotensive subjects and 109 +/- 5 nmol (+/- s.e.m.) in 26 patients with essential hypertension (P < 0.05). There was a wide overlap between the values of normotensives and hypertensives. Thus there is no positive evidence of an increased platelet intracellular free calcium concentration in a large proportion of patients with essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2856689

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  3 in total

1.  Platelet cytosolic free calcium concentration in hypertension associated with early stage kidney disease.

Authors:  H Schiffl
Journal:  Klin Wochenschr       Date:  1989-07-03

2.  [Intracellular free calcium and plasma calcium in patients with essential hypertension. Is there a correlation between extracellular and intracellular disorders of calcium regulation in essential hypertension?].

Authors:  H Haller; T Philipp
Journal:  Klin Wochenschr       Date:  1988-05-16

3.  Time-delimited signaling of MET receptor tyrosine kinase regulates cortical circuit development and critical period plasticity.

Authors:  Ke Chen; Xiaokuang Ma; Antoine Nehme; Jing Wei; Yan Cui; Yuehua Cui; Dezhong Yao; Jie Wu; Trent Anderson; Deveroux Ferguson; Pat Levitt; Shenfeng Qiu
Journal:  Mol Psychiatry       Date:  2020-01-03       Impact factor: 15.992

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.